Adastra Labs Holdings Ltd. (D2E0) AI Stock Analysis

2 Followers

Adastra Labs Holdings Ltd.

(Frankfurt:D2E0)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Specialized B2B extraction and formulationAdastra Labs operates a focused, specialty business supplying refined cannabinoid ingredients to manufacturers. That B2B ingredient model is durable: it relies on production know-how and contract relationships rather than retail foot traffic, supporting steady demand from downstream brands and potential for long-term supply agreements.

Negative Factors

Declining revenue and large lossesRevenues are declining materially while net margins are deeply negative, indicating the business is shrinking while losing cash on sales. Sustained top-line contraction combined with heavy losses undermines scale economics, limits reinvestment capacity, and makes achieving a durable turnaround more difficult without clear demand or margin recovery.

Adastra Labs Holdings Ltd. (D2E0) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 1.12M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -0.7
Beta (1Y): -2.28
Revenue Growth: ―
EPS Growth: ―
Country: Germany
Employees: 21
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

Adastra Labs Holdings Ltd. Business Overview & Revenue Model

Company Description

Adastra Holdings Ltd. is a company specializing in solutions for cannabis processing and extraction. It provides a variety of services, including comprehensive analytical testing and processing for cannabis. The company offers its processing expertis...

Adastra Labs Holdings Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:D2E0 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:LABS	53Neutral	CAD 25.63M	-5.60	-13.79%	―	-6.74%	43.54%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:AVCN	44Neutral	CAD 13.44M	-2.62	-108.44%	―	-0.23%	-142.54%
TSE:OILS	43Neutral	CAD 3.40M	-1.75	-43.92%	―	-18.30%	-397.37%
TSE:PCLO	42Neutral	CAD 9.34M	-2.67	28.59%	―	0.90%	57.73%

* Healthcare Sector Average

Performance Comparison

DE:D2E0 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:D2E0	Adastra Labs Holdings Ltd.	0.08	-0.02	-22.94%
TSE:LABS	Medipharm Labs (Otc)	0.07	-0.01	-7.14%
TSE:PCLO	Pharmacielo	0.05	0.01	11.11%
TSE:OILS	Nextleaf Solutions	0.02	-0.04	-63.64%
TSE:AVCN	Avicanna Inc	0.09	-0.17	-66.67%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Adastra Labs Holdings Ltd. AI Stock Analysis